Kiniksa Pharmaceuticals International (KNSA) Insider Trading & Ownership $28.42 +0.33 (+1.17%) Closing price 04:00 PM EasternExtended Trading$28.42 +0.00 (+0.02%) As of 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage53.48%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)7Amount OfInsider Selling(Last 12 Months)$22.49M Get KNSA Insider Trade Alerts Want to know when executives and insiders are buying or selling Kiniksa Pharmaceuticals International stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address KNSA Insider Buying and Selling by Quarter Kiniksa Pharmaceuticals International Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails7/14/2025Eben TessariCOOSell18,900$28.72$542,808.00 6/16/2025Eben TessariCOOSell17,300$28.28$489,244.00 6/11/2025Barry D QuartDirectorSell12,336$30.39$374,891.04 6/11/2025Eben TessariCOOSell45,042$30.51$1,374,231.42 6/10/2025Barry D QuartDirectorSell8,212$30.36$249,316.32 6/10/2025Eben TessariCOOSell15,506$30.46$472,312.76 6/9/2025Barry D QuartDirectorSell6,900$30.26$208,794.00 6/9/2025Eben TessariCOOSell10,319$30.38$313,491.22 6/3/2025Mark RagosaCFOSell18,299$28.80$527,011.20 6/3/2025Michael R MegnaCAOSell15,211$28.75$437,316.25 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 6/3/2025Ross MoatInsiderSell27,594$29.02$800,777.88 5/28/2025Sanj K PatelCEOSell62,116$27.33$1,697,630.28 5/27/2025Sanj K PatelCEOSell19,317$27.01$521,752.17 5/23/2025Sanj K PatelCEOSell4,837$27.00$130,599.00 5/19/2025Eben TessariCOOSell12,000$26.41$316,920.00 5/13/2025Sanj K PatelCEOSell2,872$27.03$77,630.16 5/8/2025Sanj K PatelCEOSell101$27.00$2,727.00 5/7/2025John F PaoliniInsiderSell200$27.00$5,400.00 5/7/2025Michael R MegnaCAOSell17,647$26.69$470,998.43 5/5/2025Ross MoatInsiderSell6,272$28.00$175,616.00 5/1/2025Ross MoatInsiderSell23,234$28.02$651,016.68 4/30/2025Mark RagosaCFOSell21,254$26.95$572,795.30 4/29/2025Ross MoatInsiderSell64,035$25.21$1,614,322.35 4/21/2025Ross MoatInsiderSell18,259$20.29$370,475.11 4/14/2025Eben TessariCOOSell12,000$20.48$245,760.00 3/19/2025Mark RagosaCFOSell8,879$23.10$205,104.90 3/17/2025Mark RagosaCFOSell11,464$23.10$264,818.40 3/12/2025Mark RagosaCFOSell36,372$22.25$809,277.00 3/12/2025Michael R MegnaCAOSell9,051$22.45$203,194.95 2/10/2025Eben TessariCOOSell14,000$19.57$273,980.00 1/13/2025Eben TessariCOOSell14,000$18.24$255,360.00 12/5/2024Mark RagosaCFOSell1,123$21.25$23,863.75 12/3/2024Mark RagosaCFOSell8,969$21.45$192,385.05 10/15/2024Eben TessariCOOSell17,000$26.87$456,790.00 9/23/2024Eben TessariCOOSell17,500$24.99$437,325.00 9/3/2024John F PaoliniInsiderSell60,692$26.12$1,585,275.04 8/27/2024Eben TessariCOOSell17,500$26.91$470,925.00 7/23/2024John F PaoliniInsiderSell22,000$26.32$579,040.00 7/23/2024Mark RagosaCFOSell24,248$24.79$601,107.92 7/23/2024Sanj K PatelCEOSell136,124$25.65$3,491,580.60 This Signal Only Flashes Once Every 4 Years – And It Just Triggered (Ad)This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in crypto. Now it’s back, and the smart money is already positioning. A free training reveals the step-by-step strategy and altcoin picks designed to help you capitalize on the next wave.Missed the Last Crypto Boom? Don’t Miss This One - PLUS Claim your $10 in Bitcoin (Data available from 1/1/2013 forward) KNSA Insider Trading Activity - Frequently Asked Questions Who is on Kiniksa Pharmaceuticals International's Insider Roster? The list of insiders at Kiniksa Pharmaceuticals International includes Barry D Quart, Eben Tessari, John F Paolini, Mark Ragosa, Michael R Megna, Ross Moat, and Sanj K Patel. Learn more on insiders at KNSA. What percentage of Kiniksa Pharmaceuticals International stock is owned by insiders? 53.48% of Kiniksa Pharmaceuticals International stock is owned by insiders. Learn more on KNSA's insider holdings. Which Kiniksa Pharmaceuticals International insiders have been selling company stock? The following insiders have sold KNSA shares in the last 24 months: Barry D Quart ($833,001.36), Eben Tessari ($5,649,147.40), John F Paolini ($3,236,577.04), Mark Ragosa ($3,436,363.52), Michael R Megna ($1,928,169.70), Ross Moat ($3,612,208.02), and Sanj K Patel ($6,312,966.79). How much insider selling is happening at Kiniksa Pharmaceuticals International? Insiders have sold a total of 987,780 Kiniksa Pharmaceuticals International shares in the last 24 months for a total of $25,008,433.83 sold. Kiniksa Pharmaceuticals International Key ExecutivesMr. Sanj K. Patel (Age 55)CEO & Chairman of the Board Compensation: $1.57M5 recent tradesMr. Eben Tessari (Age 42)Senior VP & COO Compensation: $733.29k8 recent tradesDr. John F. Paolini FACC (Age 59)M.D., Ph.D., Senior VP & Chief Medical Officer Compensation: $855.79kMr. Mark Ragosa C.F.A. (Age 50)Senior VP & CFO Mr. Michael R. Megna CPA (Age 53)Chief Accounting Officer & Group VP of Finance 3 recent tradesMr. Chad MorinSenior VP & Chief Compliance OfficerMs. Madelyn Demsky Zeylikman (Age 50)SVP, General Counsel & Secretary More Insider Trading Tools from MarketBeat Related Companies VRNA Insider Transactions ROIV Insider Transactions ELAN Insider Transactions RVMD Insider Transactions GRFS Insider Transactions TGTX Insider Transactions NUVL Insider Transactions LNTH Insider Transactions AXSM Insider Transactions CRSP Insider Transactions Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insider Selling Hits Market Leaders—Should You Be Worried?3 Small Caps Drawing Insider and Institutional SupportDo They Know Something? Insiders & Congress Buy UnitedHealthMicron Insiders Sell But Investors Should Buy, Buy, BuySizzling Insider Buys for Your High-Yield Watchlist This page (NASDAQ:KNSA) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredIs this secretive Asian company trying to take over Bitcoin?A mysterious Asian conglomerate is buying billions in Bitcoin — but one legendary trader says that’s the wrong...Brownstone Research | SponsoredNvidia’s next AI move could catch traders flat-footedTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredTrump has to finance $21 trillion. Here’s His Move…Trump needs $21 trillion to fund his agenda — and insiders believe he’s quietly preparing a major shift in the...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kiniksa Pharmaceuticals International, plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Kiniksa Pharmaceuticals International With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.